Binding study of lysozyme with Al(III) using chemiluminescence analysis

Enhanced acidogenic fermentation from Al-rich waste activated sludge by combining lysozyme and sodium citrate pretreatment: Perspectives of Al stabilization and enzyme activity

The accumulation of poly aluminum chloride (PAC) in dewatered waste activated sludge (WAS) can cause severe Al pollution and significantly reduce the production of volatile fatty acids (VFAs) from anaerobic fermentation. Herein, the combination of lysozyme and sodium citrate pretreatment was applied to stabilize the aluminum and enhance the VFAs production via anaerobic fermentation. The complexation and stabilization of aluminum by the citrate was efficient, which is conducive to relieving the inhibition of aluminum on lysozymes and other extracellular hydrolases. Compared with the control group, the lysozyme, protease and α-glucosidase activities were obtained at 1.86, 1.72, and 1.15 times, respectively, following the pretreatment. 129.71 mg/g volatile suspended solids (VSS) of soluble proteins and 26.3 mg/g VSS of polysaccharides were obtained within 4 h, together with the degradation of 124 % more proteins and 75 % more polysaccharides within three days. This provided a sufficient number of substrates for VFA production. 588.4 mg COD/g VSS of total VFAs were obtained after the six-day anaerobic fermentation from Al-rich WAS following the combination of lysozyme and sodium citrate pretreatment, which was 7.3 times higher than that of the control group. This study presents a novel approach for enhancing VFA production in anaerobic fermentation as well as reducing risk of Al hazards from Al-rich WAS.

Development of a new procedure for the determination of captopril in pharmaceutical formulations employing chemiluminescence and a multicommuted flow analysis approach

This paper describes a new technique for the determination of captopril in pharmaceutical formulations, implemented by employing multicommuted flow analysis. The analytical procedure was based on the reaction between hypochlorite and captopril. The remaining hypochlorite oxidized luminol that generated electromagnetic radiation detected using a homemade luminometer. To the best of our knowledge, this is the first time that this reaction has been exploited for the determination of captopril in pharmaceutical products, offering a clean analytical procedure with minimal reagent usage. The effectiveness of the proposed procedure was confirmed by analyzing a set of pharmaceutical formulations. Application of the paired t-test showed that there was no significant difference between the data sets at a 95% confidence level. The useful features of the new analytical procedure included a linear response for captopril concentrations in the range 20.0-150.0 µmol/L (r = 0.997), a limit of detection (3σ) of 2.0 µmol/L, a sample throughput of 164 determinations per hour, reagent consumption of 9 µg luminol and 42 µg hypochlorite per determination and generation of 0.63 mL of waste. A relative standard deviation of 1% (n = 6) for a standard solution containing 80 µmol/L captopril was also obtained.